Skip to main content
Die Mitgliederzeitschrift der Deutschen Pharmazeutischen Gesellschaft e.V. (DPhG) bietet aktuelle Informationen zu neuen Arzneimitteln und Forschungsentwicklungen in attraktiven Themenheften.

Publisher: Avoxa - Mediengruppe Deutscher Apotheker GmbH on behalf of Deutsche Pharmazeutische Gesellschaft e.V.

More about this publication?
Volume 3, Number 5, September 2015

Stop the bleeding: Idarucizumab als Dabigatran-Antidot vor der Zulassung
pp. 332-334(3)
Authors: Wagner, Bianca; Helmstädter, Moritz; Stierle, Sina; Uebbing, Lukas; Ebert, Roland; Peknice, Manuel; Zündorf, Ilse; Dingermann, Theo; Fürst, Robert

Favourites:
ADD

Schmerz lass nach – auf der Suche nach neuen Analgetika
pp. 334-336(3)
Authors: Gehrig, Katja; Seuffert, Katharina; Kiener, Ines Josefine; Häuser, Franziska; Reiner, David; Zündorf, Ilse; Dingermann, Theo; Fürst, Robert

Favourites:
ADD

Drugs used in ophthalmology – an overview
pp. 338-347(10)
Authors: Cheung, Sun-Yee; Hanke, Thomas; Schubert-Zsilavecz, Manfred; Riemann, Eva-Maria

Favourites:
ADD

Challenges in compounding and characteristics of individually tailored eye preparations
pp. 348-354(7)
Authors: Schlegel, Lisa Britta; Latsch, Holger

Favourites:
ADD

Proper administration of topical ophthalmics
pp. 355-361(7)
Author: Kircher, Wolfgang

Favourites:
ADD

Systemic adverse effects of various opthalmics
pp. 362-369(8)
Author: Abdel-Tawab, Mona

Favourites:
ADD

Clinical decision making in the management of dry eye disease
pp. 371-377(7)
Authors: Pfister, Elisabeth; Rose, Olaf

Favourites:
ADD

Pharmacotherapy of intraocular inflammation and conjunctivitis
pp. 378-386(9)
Authors: Dempe, Christian; Augustin, Albert J.

Favourites:
ADD

Pharmacotherapy of age-related macular degeneration (AMD)
pp. 388-399(12)
Authors: Bertelmann, Thomas; Kaymak, Hakan

Favourites:
ADD
Favourites:
ADD

To sharpen, strengthen and invigorate eye and sight
pp. 410-417(8)
Author: Lang, Ursula

Favourites:
ADD

Fragebogen
pp. 424-425(2)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content